Swei Eric, Almario Jose A, Dunbar Kerry, Yadlapati Rena, Parker Brett, Brewer-Gutierrez Olaya, Janu Peter, Murray Michael, Sohagia Amit, Diehl David L, Khara Harshit, Abu Dayyeh Barham, Sharaiha Reem, Zarnegar Rasa, Kolb Jennifer, Nguyen Ninh, Chang Kenneth, Canto Marcia I
Johns Hopkins Medical Institutions, Baltimore, MD, USA.
The Ohio State University, Columbus, OH, USA.
Surg Endosc. 2025 Oct 2. doi: 10.1007/s00464-025-12246-7.
Gastroesophageal Reflux Disease (GERD) is a common cause of chronic cough. Transoral incisionless fundoplication (TIF) or TIF with concomitant hiatal hernia repair (cTIF) may be suitable treatments. We studied the effectiveness of TIF/cTIF in patients with chronic cough and proven GERD.
Patients with proven GERD from 9 centers (TIF registry) were evaluated before and at a minimum of 6 months post TIF/cTIF. Patients with cough-predominant phenotype were identified (chief complaint of cough and reflux symptom index (RSI) troublesome cough subscore ≥ 2) and compared to those without. The primary outcome was improvement in RSI score compared to baseline. Secondary outcomes were normalization of RSI, improvement in RSI cough sub-scores, GERD symptom improvement, discontinuation of proton pump inhibitor, and patient satisfaction.
One hundred and ninety-eight patients underwent TIF/cTIF. Follow-up for 177 patients (median 12 months [IQR 6,12]) showed decrease in median RSI score from 18 [IQR 13, 27] to 5 [IQR 2, 11] (p < 0.0001). Eighty-three percent of patients with elevated baseline RSI normalized their scores. Seventy-five percent and 72% had improvement in cough when lying down and troublesome cough, respectively. Eighty-three percentsuccessfully discontinued or decreased PPI. Satisfaction improved from 5.6% at baseline to 68.8% (p < 0.0001). Patients with cough-predominant phenotype (n = 63) experienced an additional 5-point decrease in in RSI score (p = 0.01). Patients with typical GERD symptoms were more likely to have a favorable response for cough symptoms (p < 0.0001).
TIF/cTIF are effective barrier therapies for patients with cough-predominant pH-positive GERD.
胃食管反流病(GERD)是慢性咳嗽的常见病因。经口无切口胃底折叠术(TIF)或联合食管裂孔疝修补术的TIF(cTIF)可能是合适的治疗方法。我们研究了TIF/cTIF对慢性咳嗽且确诊为GERD患者的有效性。
来自9个中心(TIF注册中心)的确诊为GERD的患者在TIF/cTIF术前及术后至少6个月进行评估。确定以咳嗽为主表型的患者(主要症状为咳嗽且反流症状指数(RSI)中咳嗽困扰子评分≥2),并与无该表型的患者进行比较。主要结局是与基线相比RSI评分的改善。次要结局包括RSI正常化、RSI咳嗽子评分改善、GERD症状改善、质子泵抑制剂停药以及患者满意度。
198例患者接受了TIF/cTIF治疗。对177例患者进行随访(中位时间12个月[四分位间距6,12]),结果显示RSI评分中位数从18[四分位间距13,27]降至5[四分位间距2,11](p<0.0001)。基线RSI升高的患者中有83%评分恢复正常。分别有75%和72%的患者在躺下时咳嗽及困扰性咳嗽得到改善。83%的患者成功停用或减少了质子泵抑制剂。满意度从基线时的5.6%提高到68.8%(p<0.0001)。以咳嗽为主表型的患者(n=63)RSI评分额外降低了5分(p=0.01)。有典型GERD症状的患者对咳嗽症状更可能有良好反应(p<0.0001)。
TIF/cTIF是治疗以咳嗽为主的pH阳性GERD患者的有效抗反流治疗方法。